Request Deal Involvement
Goldman Sachs Alternatives led a $95m Series C round in Ajax Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
The Yates Network
legal advisors
Cooley
legal advisors
Latham & Watkins
or
Principals
target
AJAX THERAPEUTICS
bidder
GOLDMAN SACHS ALTERNATIVES
bidder
ELI LILLY AND COMPANY
bidder
VIVO CAPITAL LLC
bidder
RA CAPITAL MANAGEMENT
bidder
POINT72 VENTURES
bidder
ECOR1 CAPITAL
bidder
BOXER CAPITAL
bidder
SCHRODINGER INC
bidder
INNING ONE VENTURES
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite